Randomized trial of doxycycline versus josamycin for Mediterranean spotted fever.
AUTOR(ES)
Bella, F
RESUMO
We undertook a randomized clinical trial comparing therapeutic efficacy of the 1-day doxycycline regimen with the 5-day josamycin regimen for Mediterranean spotted fever. All 59 patients recovered uneventfully, and results did not significantly differ between the two schedules. One-day doxycycline therapy is an effective, easy, and inexpensive treatment. Josamycin is a useful therapeutic alternative that may be particularly convenient for pregnant women and patients with a history of allergy to tetracyclines.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=171727Documentos Relacionados
- Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever.
- Ciprofloxacin therapy for Mediterranean spotted fever.
- Deleterious effect of trimethoprim-sulfamethoxazole in Mediterranean spotted fever.
- Comparison of Western immunoblotting and microimmunofluorescence for diagnosis of Mediterranean spotted fever.
- Line blot and western blot immunoassays for diagnosis of Mediterranean spotted fever.
